EPO Patents = 4

Forward Citations = 5

Loading Chart...

15 inventors (with patents filed for the assignee):

Jeffrey Colledge (3 out of 3 patents)

Margaretha Olthoff (3 out of 3 patents)

Benno Rattel (2 out of 15 patents)

4. Ulrich Patzak (2 out of 2 patents)

5. Taoufik Ouatas (2 out of 2 patents)

6. Elfi Biedermann (2 out of 9 patents)

7. Max Hasmann (2 out of 9 patents)

8. Roland Löser (2 out of 5 patents)

9. Friedemann Reiter (2 out of 14 patents)

10. Barbara Schein (2 out of 9 patents)

11. Klaus Seibel (2 out of 13 patents)

12. Klaus Vogt (2 out of 9 patents)

13. Thomas Alfred Profitlich (1 out of 1 patent)

14. Katja Wosikowski (1 out of 6 patents)

15. Isabel Schemainda (1 out of 5 patents)

6 patents: Sort by Forward Citations

1. 11160793 - Solid dosage forms of bendamustine (2021-11-02),

2. 10993933 - Oral dosage forms of bendamustine (2021-05-04),

3. 10543196 - Oral dosage forms of bendamustine (2020-01-28),

4. 10485787 - Oral dosage forms of bendamustine and therapeutic use thereof (2019-11-26),

5. 7320993 - Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents (2008-01-22),

6. 7276524 - Pyridyl alkane acid amides as cytostatics and immunosuppressives (2007-10-02),

Astellas Deutschland GmbH is a pharmaceutical company that focuses on the development and commercialization of innovative medicines for patients with serious and life-threatening diseases. They are committed to improving the health and well-being of people around the world through their research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

6 Patents

#226 in W-8000 Munich

#5,317 in Germany

Munich, Germany

Astellas Deutschland Gmbh